Back on June 4th, I suggested that the bloom would soon be off the Elon “the next Steve Jobs” Musk, and that would express itself in the diminishment of price for SCTY and TSLA. As I put it, “One would
October 30, 2015
We will see how the overall pharma and biotech sectors hold up today on news that hit after the bell around recent sector pariah Valeant Pharmaceuticals (NYSE:VRX). Optum, the health services platform of UnitedHealth (NYSE:UNH), as well as CVS Health (NYSE:CVS)and Express Scripts (NASDAQ:ESRX) announced